{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:10:40Z","timestamp":1791202240585,"version":"4.2.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T00:00:00Z","timestamp":1321228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T00:00:00Z","timestamp":1321228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,7,12]]},"DOI":"10.1038\/onc.2011.508","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T11:39:36Z","timestamp":1321270776000},"page":"3392-3396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression"],"prefix":"10.1038","volume":"31","author":[{"given":"D","family":"M\u00e9rino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,14]]},"reference":[{"key":"BFonc2011508_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S et al. (1985). The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533\u2013538.","journal-title":"Nature"},{"key":"BFonc2011508_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.onc.1210668","volume":"27","author":"E Anderton","year":"2008","unstructured":"Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ . (2008). Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27: 421\u2013433.","journal-title":"Oncogene"},{"key":"BFonc2011508_CR3","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet P, Metcalf D, Huang DCS, Tarlinton DM, Kay TWH, K\u00f6ntgen F et al. (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735\u20131738.","journal-title":"Science"},{"key":"BFonc2011508_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. (2005). Differential targeting of pro-survival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393\u2013403.","journal-title":"Mol Cell"},{"key":"BFonc2011508_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tcb.2008.01.007","volume":"18","author":"JE Chipuk","year":"2008","unstructured":"Chipuk JE, Green DR . (2008). How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157\u2013164.","journal-title":"Trends Cell Biol"},{"key":"BFonc2011508_CR6","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1073\/pnas.0401471101","volume":"101","author":"A Egle","year":"2004","unstructured":"Egle A, Harris AW, Bouillet P, Cory S . (2004). Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 101: 6164\u20136169.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011508_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood-2009-03-212670","volume":"115","author":"A Frenzel","year":"2010","unstructured":"Frenzel A, Labi V, Chmelewskij W, Ploner C, Geley S, Fiegl H et al. (2010). Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad. Blood 115: 995\u20131005.","journal-title":"Blood"},{"key":"BFonc2011508_CR8","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1128\/MCB.00907-07","volume":"28","author":"SP Garrison","year":"2008","unstructured":"Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE et al. (2008). Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 28: 5391\u20135402.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011508_CR9","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1073\/pnas.0403286101","volume":"101","author":"MT Hemann","year":"2004","unstructured":"Hemann MT, Zilfou JT, Zhao Z, Burgess DJ, Hannon GJ, Lowe SW . (2004). Suppression of tumorigenesis by the p53 target PUMA. Proc Natl Acad Sci USA 101: 9333\u20139338.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011508_CR10","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1182\/blood-2006-10-051847","volume":"109","author":"PN Kelly","year":"2007","unstructured":"Kelly PN, Puthalakath H, Adams JM, Strasser A . (2007). Endogenous bcl-2 is not required for the development of E\u03bc-myc-induced B-cell lymphoma. Blood 109: 4907\u20134913.","journal-title":"Blood"},{"key":"BFonc2011508_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.molcel.2005.02.003","volume":"17","author":"T Kuwana","year":"2005","unstructured":"Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR et al. (2005). BH3 domains of BH3-only proteins differentially regulate bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17: 525\u2013535.","journal-title":"Mol Cell"},{"key":"BFonc2011508_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(86)90361-2","volume":"47","author":"WY Langdon","year":"1986","unstructured":"Langdon WY, Harris AW, Cory S, Adams JM . (1986). The c-myc oncogene perturbs B lymphocyte development in E\u03bc-myc transgenic mice. Cell 47: 11\u201318.","journal-title":"Cell"},{"key":"BFonc2011508_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2004.07.011","volume":"6","author":"A Letai","year":"2004","unstructured":"Letai A, Sorcinelli MD, Beard C, Korsmeyer SJ . (2004). Antiapoptotic BCL-2 is required for maintenance of a model leukemia. Cancer Cell 6: 241\u2013249.","journal-title":"Cancer Cell"},{"key":"BFonc2011508_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.200905153","volume":"186","author":"D Merino","year":"2009","unstructured":"Merino D, Giam M, Hughes PD, Siggs OM, Heger K, O'Reilly LA et al. (2009). The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins. J Cell Biol 186: 355\u2013362.","journal-title":"J Cell Biol"},{"key":"BFonc2011508_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/cdd.2008.195","volume":"16","author":"EM Michalak","year":"2009","unstructured":"Michalak EM, Jansen ES, Happo L, Cragg MS, Tai L, Smyth GK et al. (2009). Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ 16: 684\u2013696.","journal-title":"Cell Death Differ"},{"key":"BFonc2011508_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrc904","volume":"2","author":"S Pelengaris","year":"2002","unstructured":"Pelengaris S, Khan M, Evan G . (2002). c-MYC: more than just a matter of life and death. Nature Reviews Cancer 2: 764\u2013776.","journal-title":"Nature Reviews Cancer"},{"key":"BFonc2011508_CR17","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/emboj.2011.307","volume":"30","author":"A Strasser","year":"2011","unstructured":"Strasser A, Cory S, Adams JM . (2011). Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30: 3667\u20133683.","journal-title":"EMBO J"},{"key":"BFonc2011508_CR18","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1002\/j.1460-2075.1996.tb00756.x","volume":"15","author":"A Strasser","year":"1996","unstructured":"Strasser A, Elefanty AG, Harris AW, Cory S . (1996). Progenitor tumours from Em-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J 15: 3823\u20133834.","journal-title":"EMBO J"},{"key":"BFonc2011508_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/348331a0","volume":"348","author":"A Strasser","year":"1990","unstructured":"Strasser A, Harris AW, Bath ML, Cory S . (1990). Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331\u2013333.","journal-title":"Nature"},{"key":"BFonc2011508_CR20","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A et al. (2005). Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24: 1348\u20131358.","journal-title":"Oncogene"},{"key":"BFonc2011508_CR21","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1172\/JCI39964","volume":"120","author":"Z Xiang","year":"2010","unstructured":"Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opferman JT et al. (2010). Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia. J Clin Invest 120: 2109\u20132118.","journal-title":"J Clin Invest"},{"key":"BFonc2011508_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A . (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47\u201359.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011508","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:35:47Z","timestamp":1647887747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,14]]},"references-count":22,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2012,7,12]]}},"alternative-id":["BFonc2011508"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.508","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,14]]},"assertion":[{"value":"3 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}